Wednesday November 14 Poster Session 5:45 PM – 7:00 PM (4 Posters) Oral Presentations 8:00 AM – 2:00 PM
Thursday November 15 Poster Session 6:00 PM – 7:15 PM (2 Posters) Maximizing Genetic Testing Results for Hereditary Cancer Using RNA Studies 12:00 PM – 1:15 PM
Session PA-337 CSNK2B phenotypes include infantile epilepsy with myoclonic seizures Abstract CSKN2B Working Group, Zöe Powis
Session PA-52 Genetic testing alters care for von Hippel-Lindau syndrome phenocopy Abstract Carrie Horton, Morgan Depas, Amanda Jacquart
Session PA-106 Beyond FBN1: Multigene Panel Testing for Marfan syndrome Abstract Tami Johnston, Jill Dolinsky, Zöe Powis, Lily Hoang, Christian Antolik, Andy Castro
Session PA-76 When do clinicians cast a wider net? Utilization of the largest comprehensive cancer panel at one commercial laboratory Abstract Tripti Paudyal, Amal Yussuf, Sara Wienke, Jessica Profato
Session PB-44 Characteristics of patients with a primary brain tumor undergoing panel genetic testing Abstract Michelle Jackson, Sarah Azam, Leslie Dunnington, Syed Hashmi, Krista J. Qualmann, David Rodriguez-Buritica, Aarti Ramdaney
Session PB-50 Double take! Mosaic Li Fraumeni syndrome in monozygotic twins Abstract Victoria Costello, Stephany Connor, Carla Mason, Melissa Pronold
Session A01 A collaborative view of genomic variant interpretation: Clinical genetic counselors, laboratories, and patients Karen Wain, Emily Palen, Ana Morales, Kami Wolfe Schneider, Kristy Lee, Jessica Mester, Tina Pesaran, Sarah Barnett, Casie Genetti, Amanda Buchanan, Juliann Savatt, Danielle Azzariti
In a class all by itself: The importance of reclassifying genes and variants to better guide patient care Zu00f6e Powis